R1 RCM Reports Fourth Quarter and Full Year 2023 Results

by

in

MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ:RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023.

Fourth Quarter 2023 Results:

Revenue of $575.1 million, up $41.8 million or 7.8% compared to the same period last year
GAAP net income of $1.4 million, compared to a net loss of $36.6 million in the same period last year
Adjusted EBITDA of $167.7 million, up $42.1 million or 33.5% compared to the same period last year

Full Year 2023 Results:

Revenue of $2,254.2 million, up $447.8 million or 24.8% compared to 2022
GAAP net income of $3.3 million, compared to net loss of $63.3 million in 2022
Adjusted EBITDA of $614.3 million, up $190.5 million or 45.0% compared to 2022

“R1 executed on its key objectives in 2023. We established a stronger foundation for growth, stabilized key metrics for several clients and delivered approximately $30 million in synergies from the Cloudmed integration,” stated Lee Rivas, R1’s CEO. “In addition, we strengthened our technology platform by driving innovation through generative AI and enhanced our global infrastructure to improve our performance and competitive position in the market.”

Mr. Rivas added, “We enter 2024 with a more diversified business, enhanced technology initiatives and increased global scale. Our strategy is to leverage our best-in-class capabilities to deploy flexible models that meet customers where they are in their revenue cycle journey. We believe R1’s breadth of capabilities and data-driven technology platform, combined with our focus on operational excellence, positions us to drive value for our customers while delivering long-term sustainable growth and improved financial performance for our shareholders.”

2024 Outlook

For 2024, R1 expects to generate:

Revenue of between $2,625 million and $2,675 million
GAAP operating income of $105 million to $135 million
Adjusted EBITDA of $650 million to $670 million

Jennifer Williams, R1’s CFO said, “Our outlook for fiscal 2024 reflects the strength of our platform and our focus on both growth and operating discipline to deliver great value for our customers and shareholders. To further our leadership position in the industry, we will continue improving execution across our business, advancing our new business pipeline and investing in technology, while remaining committed to improving margins and cash flows.”

Supplemental Forward-Looking Information and Assumptions for Fiscal Year 2024

The Company is providing the following supplemental expectations and related assumptions regarding its fiscal year 2024 results, all of which are subject to change, to further provide transparency to investors:

Revenue of $2,625 to $2,675 million assumes the following:

Net operating fees and incentive fees remain consistent with the fourth quarter 2023 run rate (excluding Providence and Acclara contributions), with expected low single digit year-over-year cash collection growth offset by customer attrition and facility divestitures.
Modular and Other revenue assumes revenue growth in the low teens.
We anticipate Acclara and Providence to contribute revenue of approximately $290 to 295 million, and $45 to 50 million, respectively.

Capital expenditures of approximately 5% of revenue for the fiscal year.
Other expenses for the fiscal year of approximately $105 to $125 million, including integration expenses in connection with the Acclara acquisition.
Interest expense in the range of $160 to $165 million for the fiscal year, including the impact of $575 million in additional Term B Loans and the $80 million draw on the Company’s senior revolving credit facility related to the Acclara acquisition.
Depreciation and amortization expense of $330 to $350 million.

Conference Call and Webcast Details

R1’s management team will host a conference call today at 8:00 a.m. Eastern Time to discuss its financial results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at ir.r1rcm.com.

Non-GAAP Financial Measures

In order to provide a more comprehensive understanding of the information used by R1’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP cost of services, non-GAAP selling, general and administrative expenses, and net debt. Adjusted EBITDA is defined as GAAP net income (loss) before net interest income/expense, income tax provision/benefit, depreciation and amortization expense, share-based compensation expense, CoyCo 2, L.P. (“CoyCo 2”) share-based compensation expense, and certain other items, including business acquisition costs, integration costs, technology transformation, strategic initiatives, and facility-exit charges. Non-GAAP cost of services is defined as GAAP cost of services less share-based compensation expense, CoyCo 2 share-based compensation expense, and depreciation and amortization expense attributed to cost of services. Non-GAAP selling, general and administrative expenses is defined as GAAP selling, general and administrative expenses less share-based compensation expense, CoyCo 2 share-based compensation expense, and depreciation and amortization expense attributed to selling, general and administrative expenses. Net debt is defined as debt less cash and cash equivalents, inclusive of restricted cash. Adjusted EBITDA guidance is reconciled to operating income guidance, the most closely comparable available GAAP measure.

The Company’s board of directors and management team use adjusted EBITDA as (i) one of the primary methods for planning and forecasting overall expectations and for evaluating actual results against such expectations and (ii) a performance evaluation metric in determining achievement of certain executive incentive compensation programs, as well as for incentive compensation programs for employees. Non-GAAP cost of services and non-GAAP selling, general and administrative expenses are used to calculate adjusted EBITDA. Net debt is used as a supplemental measure of the Company’s liquidity.

Tables 4 through 9 present a reconciliation of GAAP financial measures to non-GAAP financial measures. Non-GAAP measures should be considered in addition to, but not as a substitute for, the information prepared in accordance with GAAP.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, included in this press release are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “designed,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “outlook,” “plan,” “predict,” “project,” “see,” “seek,” “target,” “would” and similar expressions or variations or negatives of these words are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements include, among other things, statements about the Company’s strategy, future operations, future financial position, prospects, plans, objectives of management, ability to successfully deliver on commitments to customers, ability to deploy new business as planned, ability to successfully implement new technologies, and expected market growth. Such forward-looking statements are based on management’s current expectations about future events as of the date hereof and involve many risks and uncertainties that could cause the Company’s actual results to differ materially from those expressed or implied in its forward-looking statements. Subsequent events and developments, including actual results or changes in the Company’s assumptions, may cause the Company’s views to change. The Company does not undertake to update its forward-looking statements except to the extent required by applicable law. Readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements. The Company’s actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to, economic downturns and market conditions beyond the Company’s control, including high inflation; the quality of global financial markets; the Company’s ability to timely and successfully achieve the anticipated benefits and potential synergies of the acquisitions of Cloudmed and Acclara; the Company’s ability to retain existing customers or acquire new customers; the development of markets for the Company’s revenue cycle management offering; variability in the lead time of prospective customers; competition within the market; breaches or failures of the Company’s information security measures or unauthorized access to a customer’s data; delayed or unsuccessful implementation of the Company’s technologies or services, or unexpected implementation costs; disruptions in or damages to the Company’s global business services centers and third-party operated data centers; the volatility of the Company’s stock price; the impact of the recent restatements of the financial statements for the applicable periods on the price of the Company’s common stock, reputation and relationships with its investors, suppliers, customers, employees and other parties; the Company’s substantial indebtedness; and the factors set forth under the heading “Risk Factors” in the Company’s most recent annual report on Form 10-K, and any other periodic reports that the Company may file with the U.S. Securities and Exchange Commission.

About R1 RCM

R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.

Contact:
R1 RCM Inc.

Investor Relations:

Evan Smith, CFA
516-743-5184
investorrelations@r1rcm.com

Media Relations:

Yancey Casey
Amendola Communications
678-895-9401
ycasey@acmarketingpr.com

 

Table 1

R1 RCM Inc.

Consolidated Balance Sheets

(In millions)

 
 
(Unaudited)
 
 

 
 
December 31,

 
 
 
2023
 
 
 
2022
 

Assets
 
 
 
 

Current assets:
 
 
 
 

Cash and cash equivalents
 
$
173.6
 
 
$
110.1
 

Accounts receivable, net of $48.2 million and $15.1 million allowance as of December 31, 2023 and 2022, respectively
 
 
243.3
 
 
 
235.2
 

Accounts receivable – related party, net of $0.1 million allowance as of December 31, 2023 and 2022
 
 
26.1
 
 
 
25.0
 

Current portion of contract assets, net
 
 
94.4
 
 
 
83.9
 

Prepaid expenses and other current assets
 
 
95.9
 
 
 
110.3
 

Total current assets
 
 
633.3
 
 
 
564.5
 

Property, equipment and software, net
 
 
173.7
 
 
 
164.8
 

Operating lease right-of-use assets
 
 
62.5
 
 
 
80.5
 

Non-current portion of contract assets, net
 
 
37.7
 
 
 
32.0
 

Non-current portion of deferred contract costs
 
 
30.4
 
 
 
26.7
 

Intangible assets, net
 
 
1,310.7
 
 
 
1,514.5
 

Goodwill
 
 
2,629.4
 
 
 
2,640.3
 

Non-current deferred tax assets
 
 
10.9
 
 
 
10.4
 

Other assets
 
 
71.6
 
 
 
88.1
 

Total assets
 
$
4,960.2
 
 
$
5,121.8
 

Liabilities
 
 
 
 

Current liabilities:
 
 
 
 

Accounts payable
 
$
22.7
 
 
$
33.4
 

Current portion of customer liabilities
 
 
39.8
 
 
 
57.5
 

Current portion of customer liabilities – related party
 
 
5.2
 
 
 
7.4
 

Accrued compensation and benefits
 
 
126.3
 
 
 
109.0
 

Current portion of operating lease liabilities
 
 
19.3
 
 
 
18.0
 

Current portion of long-term debt
 
 
67.0
 
 
 
53.9
 

Accrued expenses and other current liabilities
 
 
65.9
 
 
 
70.5
 

Total current liabilities
 
 
346.2
 
 
 
349.7
 

Non-current portion of customer liabilities
 
 
2.7
 
 
 
5.0
 

Non-current portion of customer liabilities – related party
 
 
11.8
 
 
 
13.7
 

Non-current portion of operating lease liabilities
 
 
77.8
 
 
 
94.4
 

Long-term debt
 
 
1,570.5
 
 
 
1,732.6
 

Non-current deferred tax liabilities
 
 
176.6
 
 
 
200.8
 

Other non-current liabilities
 
 
23.2
 
 
 
23.1
 

Total liabilities
 
 
2,208.8
 
 
 
2,419.3
 

Stockholders’ equity:
 
 
 
 

Common stock
 
 
4.5
 
 
 
4.4
 

Additional paid-in capital
 
 
3,197.4
 
 
 
3,123.3
 

Accumulated deficit
 
 
(136.7
)
 
 
(140.0
)

Accumulated other comprehensive loss
 
 
(5.9
)
 
 
(3.4
)

Treasury stock
 
 
(307.9
)
 
 
(281.8
)

Total stockholders’ equity
 
 
2,751.4
 
 
 
2,702.5
 

Total liabilities and stockholders’ equity
 
$
4,960.2
 
 
$
5,121.8
 

Table 2

R1 RCM Inc.

Consolidated Statements of Operations

(In millions, except share and per share data)

 
 
 
 
 

 
 
(Unaudited)
 
(Unaudited)
 
(Unaudited)
 
 

 
 
Three Months Ended December 31,
 
Year Ended December 31,

 
 
 
2023
 
 
2022
 
 
 
2023
 
 
2022
 

Net operating fees
 
$
369.1
 
$
344.9
 
 
$
1,455.9
 
$
1,309.7
 

Incentive fees
 
 
23.9
 
 
25.9
 
 
 
108.4
 
 
106.8
 

Modular and other
 
 
182.1
 
 
162.5
 
 
 
689.9
 


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *